PharmaCyte Biotech, Inc. Common Stock (PMCB) is a publicly traded Healthcare sector company. As of July 29, 2026, PMCB trades at $0.58 with a market cap of $6.33M and a P/E ratio of 0.18. PMCB moved +0.00% today. Year to date, PMCB is -19.13%; over the trailing twelve months it is -42.60%. Its 52-week range spans $0.57 to $1.90. Rallies surfaces PMCB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
PharmaCyte Biotech, Inc. Common Stock (PMCB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PMCB moved +0.00% today.
| Metric | Value |
|---|---|
| Price | $0.58 |
| Market Cap | $6.33M |
| P/E Ratio | 0.18 |
| EPS | $3.19 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.90 |
| 52-Week Low | $0.57 |
| Volume | 45.87K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $30.66M |
| Gross Margin | 0.00% |
PMCB analyst coverage data. Average price target: $0.00.